Skip to content Skip to footer
Subscribe Now
NEWS

Regeneron Enters a ~$3B Multi-Year Manufacturing Agreement with FUJIFILM Diosynth Biotechnologies

Shots:

  • FUJIFILM Diosynth Biotechnologies & Regeneron have entered into a 10-year manufacturing supply agreement, under which FUJIFILM will provide US-based manufacturing services for Regeneron
  • As per the deal, FUJIFILM will receive ~$3B to manufacture biopharmaceuticals for Regeneron at its Holly Springs, North Carolina facility, which will begin operations in late 2025
  • Holly Springs site is part of FUJIFILM’s global kojoX interconnected manufacturing network which offers standardized equipment, processes, & procedures across all sites to allow supply chain security & seamless tech transfers, with FUJIFILM bringing additional capacity online in 2025 & beyond

Ref: FUJIFILM Diosynth | Image: FUJIFILM Diosynth Biotechnologies & Regeneron

Related News:- Regeneron and Sanofi Report the US FDA’s Approval of Dupixent for Chronic Spontaneous Urticaria

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Tags:

You May Also Like

June 11, 2025
OS Therapies & EVERSANA Partner to Commercialize OST-HER2 in the US for Pediatric Osteosarcoma
December 10, 2025
ProVerum Receives the US FDA Approval for ProVee System to Treat Benign Prostatic Hyperplasia
OS Therapies
April 11, 2025
OS Therapies Reports Clinical Data of OST-HER2 for the Treatment of Unresected Osteosarcoma in Dogs

Contact US

 Second Floor, H-65, Sector 63 Noida, Uttar Pradesh, INDIA – 201301

 +1 (289) 778-4900

 connect@pharmashots.com

OUR INFORMATION

About Us

Announcements

FAQ

Privacy Policy

Terms & Conditions

Grievance Redressal

FOLLOW US

Contact US

Copyright © 2018 – 2026 PharmaShots – All Rights Reserved.

We chose the name PharmaShots to reflect our mission of delivering concise, high-impact, and actionable insights — or “shots” — for decision-makers across the biopharma and healthcare ecosystem. Each story, update, or insight is designed to be sharp, focused, and easy to consume, helping readers quickly grasp what truly matters in a fast-moving industry.

PharmaShots operates at the intersection of media, insights, and brand visibility for the life sciences industry. Our core offerings include:

  • Curated biopharma and healthcare news & analysis

  • Deep-dive insight reports, lists, and industry rankings

  • Sponsored content and brand storytelling

  • Digital marketing and content distribution

  • Event and congress media partnerships

  • Interviews, viewpoints, and expert-led features

  • Newsletter sponsorships and targeted outreach

All services are designed to help companies communicate value, thought leadership, and innovation to the right audience.

PharmaShots content is created and curated by experienced healthcare writers, editors, analysts, and subject-matter contributors with strong backgrounds in biopharma, life sciences, healthcare research, and business insights.

Our editorial process focuses on clarity, accuracy, and relevance, ensuring every piece delivers insight rather than noise.

Our readers come from across the global healthcare and life sciences ecosystem, including:

  • Healthcare decision-makers

  • Biopharma and biotech professionals

  • Medtech and diagnostics leaders

  • Researchers and clinicians

  • Strategy, business development, and competitive intelligence teams

  • Investors and consultants

  • Digital health and AI innovators

  • Marketing, communications, and market access professionals

They rely on PharmaShots to stay informed, make decisions faster, and spot emerging trends early.

PharmaShots is updated daily with fresh content across news, insights, interviews, and special reports. Updates may occur daily or multiple times per week depending on industry activity, major announcements, and ongoing coverage themes.

Readers can stay connected with PharmaShots through multiple channels:

  • Subscribe to our email newsletter for curated weekly updates

  • Follow PharmaShots on LinkedIn and other social platforms

  • Visit the website regularly for new stories and reports

  • Engage with special editions, rankings, and event coverage

These channels ensure you never miss key developments shaping biopharma and healthcare.

You can reach out to PharmaShots through our website’s contact page or via email at connect@pharmashots.com for inquiries, collaborations, or feedback. Visit pharmashots.com for more details

For general inquiries, partnerships, media collaborations, or support, you can reach us at:

Email: connect@pharmashots.com

Address: PharmaShots Media Private Limited

Second Floor, H-65, Sector 63
Noida, Uttar Pradesh, India – 201301

Phone: India: +91 9582 193319 

US/Canada: +1 (289) 778-4900